KR20240018800A - One step sample pretreatment method for rapid quantitative test of oral bacteria - Google Patents

One step sample pretreatment method for rapid quantitative test of oral bacteria Download PDF

Info

Publication number
KR20240018800A
KR20240018800A KR1020220096546A KR20220096546A KR20240018800A KR 20240018800 A KR20240018800 A KR 20240018800A KR 1020220096546 A KR1020220096546 A KR 1020220096546A KR 20220096546 A KR20220096546 A KR 20220096546A KR 20240018800 A KR20240018800 A KR 20240018800A
Authority
KR
South Korea
Prior art keywords
bacterial
bacteria
sample
qpcr
chelex
Prior art date
Application number
KR1020220096546A
Other languages
Korean (ko)
Inventor
이기자
이영주
안병기
Original Assignee
주식회사 덴오믹스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 덴오믹스 filed Critical 주식회사 덴오믹스
Priority to KR1020220096546A priority Critical patent/KR20240018800A/en
Priority to PCT/KR2023/011397 priority patent/WO2024029950A1/en
Publication of KR20240018800A publication Critical patent/KR20240018800A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06Lysis of microorganisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6851Quantitative amplification

Abstract

본 발명은 구강 내 세균 신속 정량검사를 위한 원스텝 시료 전처리 방법에 관한 것으로서, 상세하게는, 현장에서 간단하고 빠르게 세균 분석을 시행하기 위하여, 별도의 세균 DNA 추출과정 없이 원스텝의 시료 전처리 후 바로 qPCR을 시행할 수 있는 전처리 방법을 개발하였다. 세균을 잘 용해시키기 위해서는 세균 용해액(lysis buffer)의 구성이 중요한데, DNA를 추출하지 않고 바로 PCR 분석을 하려면 반응을 저해하는 여러 성분들이 포함되지 않아야 하고 효소 등의 추가는 비용 상승 및 유지, 보관의 문제를 발생할 수 있는데, 세균 용해액(lysis buffer)의 조성을 최적화하면서, 세균 용해를 극대화하기 위해 열 용해(thermal lysis)와 약간의 물리적 자극을 추가하는 방법을 개발하였다. 본 발명을 기반으로 개발되는 원스텝 검체 전처리 방법을 활용하게 되면, 최종적으로 1시간 이내에 qPCR 분석이 가능한 세균 신속 검사를 통해 치주염, 치은염 등의 구강 질환 뿐 아니라, 구강 건강과 연관되는 여러 전신 질환들의 조기 진단 및 예방 관리에도 효과적으로 활용될 수 있을 것으로 기대된다.The present invention relates to a one-step sample preparation method for rapid quantitative testing of oral bacteria. In detail, in order to perform simple and fast bacterial analysis in the field, qPCR is performed immediately after one-step sample preparation without a separate bacterial DNA extraction process. A pretreatment method that can be implemented was developed. In order to dissolve bacteria well, the composition of the lysis buffer is important. If you want to perform PCR analysis directly without extracting DNA, it must not contain various components that inhibit the reaction, and adding enzymes increases costs and requires maintenance and storage. Problems may arise, and a method was developed that adds thermal lysis and some physical stimulation to maximize bacterial lysis while optimizing the composition of the lysis buffer. By using the one-step sample preprocessing method developed based on the present invention, the final bacterial rapid test capable of qPCR analysis within 1 hour can be used to detect not only oral diseases such as periodontitis and gingivitis, but also various systemic diseases related to oral health at an early stage. It is expected that it can be effectively used for diagnosis and preventive management.

Description

구강 내 세균 신속 정량검사를 위한 원스텝 시료 전처리 방법{One step sample pretreatment method for rapid quantitative test of oral bacteria}One step sample pretreatment method for rapid quantitative test of oral bacteria}

본 발명은 구강 내 세균 신속 정량검사를 위한 원스텝 시료 전처리 방법에 대한 것이다.The present invention relates to a one-step sample preparation method for rapid quantitative testing of oral bacteria.

구강 마이크로바이옴은 구강 내 존재하고 있는 미생물들과 이들의 유전정보 전체를 말하는 것으로, 구강 미생물 총의 생태계 균형이 불균형 상태로 전환될 때나 구강 미생물총의 복잡성이 증대될 때 가장 흔한 구강질환이자 감염성 질환에 속하는 치아우식증이나 치주질환이 발생한다. 뿐만 아니라, 치주질환은 당뇨, 심혈관질환, 치매 등 전신질환의 발병위험을 높이는 것으로 알려졌고 류마티스관절염의 경우 1.93 배까지 발병위험이 높아지는 것으로 보고되었다. 이는 치주염을 일으키는 대표적인 그람음성 혐기성 세균인 Porphyromonas gingivalis가 peptidylarginine deiminase(PADs)를 분비하여 류마티스관절염의 항CCP 항체(anti-cyclic citrullinated peptide Ab) 생성에 기여하기 때문으로 알려져있다. 따라서 구강 내 세균에 대한 정확한 분석은 구강질환의 진단 뿐 아니라 전신질환에 대한 예방, 관리에도 큰 도움을 줄 수 있다. The oral microbiome refers to the microorganisms present in the oral cavity and their entire genetic information. It is the most common oral disease and infectious disease when the ecological balance of the oral microbiota is shifted to an imbalanced state or when the complexity of the oral microbiota increases. Dental caries and periodontal disease, which are diseases, occur. In addition, periodontal disease is known to increase the risk of developing systemic diseases such as diabetes, cardiovascular disease, and dementia, and in the case of rheumatoid arthritis, the risk of developing rheumatoid arthritis has been reported to increase by up to 1.93 times. This is Porphyromonas , a representative gram-negative anaerobic bacterium that causes periodontitis. It is known that gingivalis secretes peptidylarginine deiminase (PADs), which contributes to the production of anti-CCP antibodies (anti-cyclic citrullinated peptide Ab) in rheumatoid arthritis. Therefore, accurate analysis of oral bacteria can be of great help not only in the diagnosis of oral diseases but also in the prevention and management of systemic diseases.

구강 세균 검사는 크게 시료 전처리와 real-time PCR 분석으로 나눌 수 있는데, real-time PCR 분석은 기기에서 시행되는 반면, 시료 전처리의 경우에는 반드시 전문 인력에 의해서 이루어져야 하고 기기와 기구들을 이용하여 여러 단계의 복잡한 과정이 시행해야 하기 때문에 노동집약적인 과정이 필요하다.Oral bacterial testing can be largely divided into sample preparation and real-time PCR analysis. While real-time PCR analysis is performed on a device, sample preparation must be performed by professional personnel and involves several steps using devices and instruments. Because a complex process must be implemented, a labor-intensive process is required.

한국등록특허 제10-1467371호(2014.11.25 등록)Korean Patent No. 10-1467371 (registered on November 25, 2014)

본 발명의 목적은 Tris-HCl, NaCl, SDS, Nonidet P-40 및 Chelex-100S가 함유된 세균 용해액(lysis buffer)을 유효성분으로 포함하는 시료 전처리용 조성물 및 상기 조성물을 이용한 시료 전처리 방법을 제공하는데 있다. The object of the present invention is to provide a sample pretreatment composition containing a bacterial lysis buffer containing Tris-HCl, NaCl, SDS, Nonidet P-40, and Chelex-100S as an active ingredient, and a sample pretreatment method using the composition. It is provided.

상기 목적을 달성하기 위하여, 본 발명은 Tris-HCl, NaCl, SDS, Nonidet P-40 및 Chelex-100S를 포함하는 세균 용해액(lysis buffer)에 시료를 첨가하는 단계; 및 상기 시료가 첨가된 세균 용해액을 70 내지 95℃에서, 10 내지 30분 동안 반응시키면서, 볼텍싱(vortexing) 또는 탭핑(tapping)하는 단계를 포함하는 시료 전처리 방법을 제공한다.In order to achieve the above object, the present invention includes the steps of adding a sample to a bacterial lysis buffer containing Tris-HCl, NaCl, SDS, Nonidet P-40, and Chelex-100S; and reacting the bacterial lysate to which the sample was added at 70 to 95° C. for 10 to 30 minutes while vortexing or tapping the sample.

또한, 본 발명은 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.1 내지 0.2 % SDS, 1 % Nonidet P-40 및 2.5 내지 20 % Chelex-100S가 최종농도로 함유된 세균 용해액(lysis buffer)을 유효성분으로 포함하는 시료 전처리용 조성물을 제공한다.In addition, the present invention is a bacterial lysate (lysis) containing a final concentration of 50mM Tris-HCl (pH 7.4), 150mM NaCl, 0.1 to 0.2% SDS, 1% Nonidet P-40 and 2.5 to 20% Chelex-100S. Provides a composition for sample pretreatment containing buffer) as an active ingredient.

본 발명은 구강 내 세균 신속 정량검사를 위한 원스텝 시료 전처리 방법에 관한 것으로서, 상세하게는, 현장에서 간단하고 빠르게 세균 분석을 시행하기 위하여, 별도의 세균 DNA 추출과정 없이 원스텝의 시료 전처리 후 바로 qPCR을 시행할 수 있는 전처리 방법을 개발하였다. 세균을 잘 용해시키기 위해서는 세균 용해액(lysis buffer)의 구성이 중요한데, DNA를 추출하지 않고 바로 PCR 분석을 하려면 반응을 저해하는 여러 성분들이 포함되지 않아야 하고 효소 등의 추가는 비용 상승 및 유지, 보관의 문제를 발생할 수 있는데, 세균 용해액(lysis buffer)의 조성을 최적화하면서, 세균 용해를 극대화하기 위해 열 용해(thermal lysis)와 약간의 물리적 자극을 추가하는 방법을 개발하였다. 본 발명을 기반으로 개발되는 원스텝 검체 전처리 방법을 활용하게 되면, 최종적으로 1시간 이내에 qPCR 분석이 가능한 세균 신속 검사를 통해 치주염, 치은염 등의 구강 질환 뿐 아니라, 구강 건강과 연관되는 여러 전신 질환들의 조기 진단 및 예방 관리에도 효과적으로 활용될 수 있을 것으로 기대된다.The present invention relates to a one-step sample preparation method for rapid quantitative testing of oral bacteria. In detail, in order to perform simple and fast bacterial analysis in the field, qPCR is performed immediately after one-step sample preparation without a separate bacterial DNA extraction process. A pretreatment method that can be implemented was developed. In order to dissolve bacteria well, the composition of the lysis buffer is important. If you want to perform PCR analysis directly without extracting DNA, it must not contain various components that inhibit the reaction, and adding enzymes increases costs and requires maintenance and storage. Problems may arise, and a method was developed that adds thermal lysis and some physical stimulation to maximize bacterial lysis while optimizing the composition of the lysis buffer. By using the one-step sample preprocessing method developed based on the present invention, the final bacterial rapid test capable of qPCR analysis within 1 hour can be used to detect not only oral diseases such as periodontitis and gingivitis, but also various systemic diseases related to oral health at an early stage. It is expected that it can be effectively used for diagnosis and preventive management.

도 1은 온도 변화에 의한 qPCR 분석 결과(3종 세균)를 나타낸다.
도 2는 온도 변화에 의한 qPCR 분석 결과(S. mutans)를 나타낸다.
도 3은 반응시간 변경에 따른 qPCR 분석 결과(S. mutans, 70℃)를 나타낸다.
도 4는 물리적 자극 여부에 의한 qPCR 분석 결과(3종 세균)를 나타낸다.
도 5는 1-step 전처리용 세균 용해액 최적화를 위한 qPCR 결과(그람양성 3종 세균)를 나타낸다.
Figure 1 shows qPCR analysis results (3 types of bacteria) by temperature change.
Figure 2 shows qPCR analysis results ( S. mutans ) by temperature change.
Figure 3 shows qPCR analysis results according to change in reaction time ( S. mutans , 70°C).
Figure 4 shows qPCR analysis results (3 types of bacteria) with or without physical stimulation.
Figure 5 shows qPCR results (three types of Gram-positive bacteria) for optimizing bacterial lysate for 1-step pretreatment.

본 발명은 Tris-HCl, NaCl, SDS, Nonidet P-40 및 Chelex-100S를 포함하는 세균 용해액(lysis buffer)에 시료를 첨가하는 단계; 및 상기 시료가 첨가된 세균 용해액을 70 내지 95℃에서, 10 내지 30분 동안 반응시키면서, 볼텍싱(vortexing) 또는 탭핑(tapping)하는 단계를 포함하는 시료 전처리 방법을 제공한다.The present invention includes the steps of adding a sample to a bacterial lysis buffer containing Tris-HCl, NaCl, SDS, Nonidet P-40, and Chelex-100S; and reacting the bacterial lysate to which the sample was added at 70 to 95° C. for 10 to 30 minutes while vortexing or tapping the sample.

바람직하게는, 상기 세균 용해액(lysis buffer)은 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.1 내지 0.2 % SDS, 1 % Nonidet P-40 및 2.5 내지 20 % Chelex-100S를 최종 농도로 포함할 수 있으나, 이에 제한되는 것은 아니다.Preferably, the bacterial lysis buffer has a final concentration of 50mM Tris-HCl (pH 7.4), 150mM NaCl, 0.1 to 0.2% SDS, 1% Nonidet P-40 and 2.5 to 20% Chelex-100S. It may include, but is not limited to this.

바람직하게는, 상기 시료는 세균이 포함된 것으로 의심되는 객체의 분변, 소변, 눈물, 타액, 피부의 외부 분비물, 호흡관의 외부 분비물, 장관의 외부 분비물, 소화관의 외부 분비물, 혈장, 혈청, 혈액, 척수액, 림프액, 체액 및 조직일 수 있으나, 이에 제한되는 것은 아니다. 보다 바람직하게는 상기 시료는 타액일 수 있다. Preferably, the sample includes feces, urine, tears, saliva, external secretions of the skin, external secretions of the respiratory tract, external secretions of the intestinal tract, external secretions of the digestive tract, plasma, serum, blood of an object suspected of containing bacteria. , spinal fluid, lymphatic fluid, body fluid, and tissue, but is not limited thereto. More preferably, the sample may be saliva.

보다 바람직하게는, 상기 시료는 스트렙토코커스 소브리누스(Streptococcus sobrinus), 스트렙토코커스 뮤탄스(Streptococcus mutans) 또는 아이케넬라 코로덴스(Eikenella corrodens)가 포함된 시료일 수 있으나, 이에 제한되는 것은 아니다.More preferably, the sample may be a sample containing Streptococcus sobrinus, Streptococcus mutans , or Eikenella corrodens , but is not limited thereto.

또한, 본 발명은 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.1 내지 0.2 % SDS, 1 % Nonidet P-40 및 2.5 내지 20 % Chelex-100S가 최종농도로 함유된 세균 용해액(lysis buffer)을 유효성분으로 포함하는 시료 전처리용 조성물을 제공한다.In addition, the present invention is a bacterial lysate (lysis) containing a final concentration of 50mM Tris-HCl (pH 7.4), 150mM NaCl, 0.1 to 0.2% SDS, 1% Nonidet P-40 and 2.5 to 20% Chelex-100S. Provides a composition for sample pretreatment containing buffer) as an active ingredient.

바람직하게는, 상기 시료는 타액일 수 있으며, 보다 바람직하게는, 상기 시료는 스트렙토코커스 소브리누스(Streptococcus sobrinus), 스트렙토코커스 뮤탄스(Streptococcus mutans) 또는 아이케넬라 코로덴스(Eikenella corrodens)가 포함된 시료일 수 있으나, 이에 제한되는 것은 아니다.Preferably, the sample may be saliva, and more preferably, the sample contains Streptococcus sobrinus , Streptococcus mutans , or Eikenella corrodens . It may be a sample, but is not limited thereto.

상기 조성물에는 효과적인 시료 전처리에 필요한 pH 조절 등을 위한 완충액 등이 추가적으로 포함될 수 있다. The composition may additionally include a buffer solution for pH adjustment necessary for effective sample pretreatment.

이하에서는, 본 발명을 한정하지 않는 실시예에 따라 본 발명을 상세히 설명한다. 본 발명의 하기 실시예는 본 발명을 구체화하기 위한 것일 뿐 본 발명의 권리범위를 제한하거나 한정하는 것이 아님은 물론이다. 따라서, 본 발명의 상세한 설명 및 실시예로부터 본 발명이 속하는 기술분야의 전문가가 용이하게 유추할 수 있는 것은 본 발명의 권리범위에 속하는 것으로 해석된다. Below, the present invention will be described in detail according to examples that do not limit the present invention. Of course, the following examples of the present invention are only intended to embody the present invention and do not limit or limit the scope of the present invention. Accordingly, what can be easily inferred by an expert in the technical field to which the present invention belongs from the detailed description and examples of the present invention is interpreted to fall within the scope of the rights of the present invention.

<< 실시예Example 1> 1-step 전처리용 세균 용해액 ( 1> Bacterial lysate for 1-step pretreatment ( lysislysis buffer) 제작 buffer) production

세균 용해력을 가진 화학 물질인 다양한 계면활성제, chaotropic 시약, salt 등의 성분으로 세균 용해액을 제작하였다. 세균을 용해시킨 용해물(lysate) 자체를 qPCR의 주형(template)으로 사용하게 되므로, 세균벽의 파괴와 함께 qPCR 증폭에 방해를 주지 않는 세균 용해액을 선정해야 한다.A bacterial lysate was prepared using ingredients such as various surfactants, chaotropic reagents, and salts, which are chemical substances with bacterial lytic power. Since the lysate itself is used as a template for qPCR, a bacterial lysate that does not destroy the bacterial wall and interfere with qPCR amplification must be selected.

1-step 전처리용 후보 세균 용해액 종류는 표 1에 나타냈다.The types of candidate bacterial lysates for 1-step pretreatment are shown in Table 1.

세균 용해액 bacterial lysate 조성Furtherance 1One LysisLysis buffer 1-1 (LB1-1) buffer 1-1 (LB1-1) 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% Nonidet P-40 50mM Tris-HCl (pH 7.4), 150mM NaCl, 1% Nonidet P-40 22 LysisLysis buffer 1-2 (LB1-2) buffer 1-2 (LB1-2) 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 5% Nonidet P-40 50mM Tris-HCl (pH 7.4), 150mM NaCl, 5% Nonidet P-40 33 LysisLysis buffer 2 buffer 2
(LB2)(LB2)
50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% Nonidet P-40, 0.1% SDS, 2 mM EDTA 50mM Tris-HCl (pH 7.4), 150mM NaCl, 1% Nonidet P-40, 0.1% SDS, 2mM EDTA
44 LysisLysis buffer 3 buffer 3
(LB3)(LB3)
50 mM Tris-HCl (pH 7.4), 6 M guanidinium HCl, 300 mM NaCl, 1% Nonidet P-40, 2 mM EDTA 50mM Tris-HCl (pH 7.4), 6M guanidinium HCl , 300mM NaCl , 1% Nonidet P-40 , 2mM EDTA
55 LysisLysis buffer 4-1 buffer 4-1
(LB4-1)(LB4-1)
50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.1 % SDS, 1% Nonidet P-40 50mM Tris-HCl (pH 7.4), 150mM NaCl, 0.1% SDS , 1% Nonidet P-40
66 LysisLysis buffer 4-2 buffer 4-2
(LB4-2)(LB4-2)
50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.2 % SDS, 1% Nonidet P-4050mM Tris-HCl (pH 7.4), 150mM NaCl, 0.2% SDS , 1% Nonidet P-40
77 LysisLysis buffer 5 buffer 5
(LB5)(LB5)
50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.5 M NaOH, 0.1 % SDS50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.5 M NaOH , 0.1% SDS
88 LysisLysis buffer 6 buffer 6
(LB6)(LB6)
10 mg/ml SB3-14*, 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% Nonidet P-40 10 mg/ml SB3-14 *, 50mM Tris-HCl (pH 7.4), 150mM NaCl, 1% Nonidet P-40
99 LysisLysis buffer 7 buffer 7
(LB7)(LB7)
EMIM Ac** : 10 mM Tris-HCl (9:1) EMIM Ac **: 10mM Tris-HCl (9:1)

* SB3-14 : 3-(N,N-Dimethylmyristylammonio)propanesulfonate* SB3-14: 3-(N,N-Dimethylmyristylammonio)propanesulfonate

** EMIM Ac : 1-ethyl-3-methylimidazolium acetate**EMIM Ac: 1-ethyl-3-methylimidazolium acetate

<< 실시예Example 2> 세균 용해액 선정 및 용해 조건 최적화 2> Selection of bacterial lysate and optimization of lysis conditions

총 9종의 용해액에 대해 반응온도 95℃, 반응시간 10분을 고정하고 4회의 tapping (2분 30초 간격)를 실시하여 제작한 세균 용해물(lysate)에 대하여, 그람 양성균은 단단한 세포벽을 가진 후벽균문 (Firmicutes)의 primer (F-primer)로, 그람음성균은 16s rRNA primer (16s-primer)로 qPCR을 실시하여 PCR 증폭이 잘 이루어지는 용해액을 1차로 선정하였다.Regarding bacterial lysates prepared by fixing a reaction temperature of 95°C and a reaction time of 10 minutes for a total of 9 types of lysate and performing 4 tappings (at 2 minutes and 30 second intervals), Gram-positive bacteria have a hard cell wall. qPCR was performed using a primer (F-primer) for Firmicutes and a 16s rRNA primer (16s-primer) for Gram-negative bacteria, and the lysate that amplified PCR well was selected as the first.

1. 세균 용해액 1차 선정1. First selection of bacterial lysate

(1) 그람 양성균 3종 (S. sobrinus , S. mutans , L. casei , 1×107 colony forming unit (CFU))과 그람 음성균 1종 (E. corrodens, 1×107 CFU)을, 제작된 9종의 세균 용해액 200 μL를 첨가하여 95℃에서 10분간 반응시키면서 4회의 tapping을 실시하였다. 이때 세균 용해액의 양성대조군은 상용화된 시약 PCRopsisTM Reagent SRVD (Entopsis)를 이용하였다.(1) Produce 3 types of Gram-positive bacteria ( S. sobrinus , S. mutans , L. casei , 1×10 7 colony forming unit (CFU)) and 1 type of Gram-negative bacteria ( E. corrodens , 1×10 7 CFU). 200 μL of the 9 bacterial lysates were added and incubated at 95°C for 10 minutes, followed by tapping four times. At this time, the commercially available reagent PCRopsis TM Reagent SRVD (Entopsis) was used as a positive control of the bacterial lysate.

(2) 후보 용해액들의 세균 용해력을 확인하기 위해, 원심분리 (12000 rpm, 10분)를 실시하여 상층액 1 μL를 qPCR의 주형(template)으로 사용하였다. 그람 양성균 3종은 10 μL 2X master mix, 2 μL F-primer, 7 μL DW로 최종 20 μL를 맞추어 PCR 장비에서 초기 변성(98℃; 1분-1 cycle)을 시킨 후 3-step PCR 조건으로 변성 98℃; 1초, 결합 56℃; 1초, 신장 72℃; 30초, 30 cycles을 실시하였다. 그람음성균 1종은 10 μL 2X master mix, 2 μL 16s-primer, 7 μL DW로 최종 20 μL를 맞추어 PCR 장비에서 초기 변성(98℃; 1분-1 cycle)을 시킨 후 3-step PCR 조건으로 변성 98℃; 1초, 결합 68℃; 30초, 신장 72℃; 45초, 30 cycles을 실시하였다. qPCR의 양성대조군은 각 세균의 DNA, 음성 대조군은 DW를 사용하였다. (2) To confirm the bacterial lytic ability of the candidate lysates, centrifugation (12000 rpm, 10 minutes) was performed and 1 μL of the supernatant was used as a template for qPCR. For the three types of Gram-positive bacteria, make a final 20 μL of 10 μL 2 denaturation 98°C; 1 second, binding 56°C; 1 second, height 72°C; 30 seconds, 30 cycles were performed. For one type of Gram-negative bacteria, make a final 20 μL of 10 μL 2 denaturation 98°C; 1 second, binding 68°C; 30 seconds, height 72°C; 45 seconds, 30 cycles were performed. DNA of each bacterium was used as a positive control for qPCR, and DW was used as a negative control.

(3) 그 결과, 1×107 CFU의 세균에 대해, LB1-1, LB4-1, LB4-2의 용해액에서만 PCR 증폭이 확인되었다.(3) As a result, PCR amplification was confirmed only in the lysates of LB1-1, LB4-1, and LB4-2 for 1 × 10 7 CFU of bacteria.

9종 세균 용해액을 이용한 qPCR의 cycle threshold value (Ct값) 결과는 표 2에 나타냈다.The cycle threshold value (Ct value) results of qPCR using 9 types of bacterial lysates are shown in Table 2.

BacteriaBacteria Cycle threshold (Ct) value Cycle threshold (Ct) value 양성positivity LB1-1LB1-1 LB1-2LB1-2 LB2LB2 LB3LB3 LB4-1LB4-1 F-primerF-primer S. S. sobrinussobrinus 17.4117.41 24.9524.95 00 00 24.7224.72 24.7224.72 S. S. mutansmutans 15.9715.97 20.4820.48 00 00 20.2620.26 20.2620.26 L. L. caseicasei 17.8017.80 23.5823.58 00 00 24.1224.12 24.1224.12 16s-primer16s-primer E. E. corrodenscorrodens 18.6018.60 24.7224.72 00 00 23.0723.07 23.0723.07 BacteriaBacteria Cycle threshold (Ct) value Cycle threshold (Ct) value LB4-2LB4-2 LB5LB5 LB6LB6 LB7LB7 고마thanks SRVD S.R.V.D. 음성voice F-primerF-primer S.S. sobrinussobrinus 24.0924.09 00 00 24.0924.09 22.0922.09 00 S.S. mutansmutans 20.5820.58 00 00 20.5820.58 19.8219.82 00 L.L. caseicasei 25.3125.31 00 00 25.3125.31 25.4225.42 00 16s-primer16s-primer E. E. corrodenscorrodens 22.3822.38 00 00 22.3822.38 23.5823.58 00

2. 세균 용해 조건 최적화2. Optimization of bacterial lysis conditions

1차 선정된 세균 용해액의 Ct값은 전체적으로 유사하여, 그중 LB4-1 용액을 사용해서 세균 용해 조건을 최적화하였다. 단, LB4-1 용액에 Chelex-100-small (Chelex-100S)을 추가하였다.The Ct values of the first selected bacterial lysates were similar overall, and the bacterial lysis conditions were optimized using the LB4-1 solution. However, Chelex-100-small (Chelex-100S) was added to the LB4-1 solution.

(1) 반응 온도(1) Reaction temperature

반응온도를 각각 상온(RT)과 95℃에서 그대로 두고 (static) 세균 용해를 진행하였다. 이때, 반응시간은 10분으로 고정하였다. 그람 양성균은 F-primer로, 그람 음성균은 16s primer를 이용하여 qPCR을 실시하였고 Ct값이 낮은 조건으로 선정하였다(Ct값은 샘플 DNA 농도의 상대적 측정값으로, 동일한 반응조건에서 세균이 잘 용해될수록 샘플 내 DNA 농도가 높게 되어 낮은 Ct값을 나타내게 됨).Bacterial lysis was performed while the reaction temperature was kept at room temperature (RT) and 95°C, respectively. At this time, the reaction time was fixed at 10 minutes. qPCR was performed using F-primer for Gram-positive bacteria and 16s primer for Gram-negative bacteria, and conditions with low Ct values were selected (Ct value is a relative measure of sample DNA concentration; the better the bacteria are lysed under the same reaction conditions) The DNA concentration in the sample becomes high, resulting in a low Ct value).

① 그람양성균 S. sobrinus, S. mutans와 그람음성균 E. corrodens (1×107 CFU/mL)에 10% Chelex-100S가 첨가된 LB4-1 용액 1 mL을 처리하여, RT와 95℃에서 10분간 그대로 두고 세균을 용해 시켰다.① Treat Gram-positive bacteria S. sobrinus , S. mutans , and Gram-negative bacteria E. corrodens (1× 107 CFU/mL) with 1 mL of LB4-1 solution containing 10% Chelex-100S, and incubate for 10 minutes at RT and 95°C. It was left for a minute to dissolve the bacteria.

② 원심분리 (12000 rpm, 10분)를 실시하여 상층액 1 μL를 qPCR의 template로 사용하며, F-primer & 16s primer를 이용하여 qPCR을 실시하였다. 양성대조군은 각 세균의 DNA, 음성 대조군은 DW를 사용하였다. ② Centrifugation (12000 rpm, 10 minutes) was performed, 1 μL of the supernatant was used as a template for qPCR, and qPCR was performed using F-primer & 16s primer. DNA of each bacterium was used as a positive control, and DW was used as a negative control.

③ 그 결과, 1×107 CFU/mL의 세균에 대해, RT보다는 95℃에서 세균 파괴가 더 많이 이루어져 Ct값이 낮음을 확인하였다.③ As a result, it was confirmed that for 1×10 7 CFU/mL of bacteria, more bacteria were destroyed at 95°C than at RT, resulting in a lower Ct value.

온도 변화에 의한 qPCR 분석 결과(3종 세균)는 표 3 및 도 1에 나타냈다.The qPCR analysis results (3 types of bacteria) by temperature change are shown in Table 3 and Figure 1.

BacteriaBacteria Ct value CT value Positive controlPositive control RTRT 95℃95℃ F-primerF-primer S. S. sobrinussobrinus 19.4719.47 28.7328.73 27.4127.41 S. S. mutansmutans 18.1918.19 27.8327.83 26.7826.78 16s primer16s primer E. E. corrodenscorrodens 18.618.6 27.7527.75 24.7224.72

다음으로는, 반응온도를 각각 상온(RT), 70, 95℃에서 vortex를 4회 실시하면서 세균 용해를 진행하였다. 이때, 반응시간은 10분으로 고정하였다.Next, bacterial lysis was performed by vortexing four times at reaction temperatures of room temperature (RT), 70, and 95°C, respectively. At this time, the reaction time was fixed at 10 minutes.

① 그람양성균 S. mutans (1×107 CFU/mL)에 10% Chelex-100S가 첨가된 LB4-1 용액 1 mL을 처리하여, RT, 70, 95℃에서 10분간 반응시키면서 vortex를 4회 (2분 30초 간격) 시행하여 세균을 용해 시켰다.① Gram-positive bacteria S. mutans (1×10 7 CFU/mL) was treated with 1 mL of LB4-1 solution containing 10% Chelex-100S, reacted at RT, 70, 95°C for 10 minutes, and vortexed 4 times (2 minutes and 30 seconds apart). This was performed to dissolve the bacteria.

② 원심분리 (12000 rpm, 10분)를 실시하여 상층액 5 μL를 qPCR의 template로 사용하고 S. mutans primer-probe (S.m PP)를 이용하여 qPCR을 실시하였다. 10 μL 2X master mix, 2 μL 세균 PP (S.m PP), 3 μL DW로 최종 20 μL를 맞추어 qPCR 장비에서 초기 변성(95℃; 10분-1 cycle)을 시킨 후 2-step PCR 조건, 변성 95℃; 15초, 결합 & 신장 60℃; 1분-45 cycles로 실시하였다. ② Centrifugation (12000 rpm, 10 minutes) was performed, 5 μL of the supernatant was used as a template for qPCR, and qPCR was performed using S. mutans primer-probe ( Sm PP). Mix the final 20 μL with 10 μL 2X master mix, 2 μL bacterial PP ( Sm PP), and 3 μL DW, and perform initial denaturation (95°C; 10 minutes - 1 cycle) in a qPCR equipment. 2-step PCR conditions, denaturation 95 ℃; 15 seconds, binding & elongation 60°C; It was carried out for 1 minute - 45 cycles.

③ 위의 결과와 마찬가지로, 1×107 CFU/mL의 세균에 대해 95℃에서 세균 파괴가 가장 많이 이루어짐을 확인하였다. 더 낮은 온도에서 세균 용해가 이루어지기 위해서는 반응시간의 증가가 필요할 것으로 판단되었다. ③ Similar to the above results, it was confirmed that the greatest amount of bacterial destruction occurred at 95°C for bacteria of 1×10 7 CFU/mL. It was judged that an increase in reaction time would be necessary to achieve bacterial lysis at lower temperatures.

온도 변화에 의한 qPCR 분석 결과(S. mutans)는 표 4 및 도 2에 나타냈다.The qPCR analysis results by temperature change ( S. mutans ) are shown in Table 4 and Figure 2.

BacteriaBacteria Ct value CT value Positive controlPositive control RTRT 70℃70℃ 95℃95℃ S.m-primer Sm -primer S. S. mutansmutans 18.9418.94 27.9827.98 26.5226.52 25.6425.64

(2) 반응 시간(2) reaction time

반응온도 95℃와 LB4-1 용액 (Chelex-100S 추가), tapping 4회를 고정하고, 반응시간을 각각 5 ~ 15분으로 변경하며 세균 용해를 진행하여 샘플을 준비하였다. 그람 양성균은 F-primer로, 그람 음성균은 16s primer를 이용하여 qPCR을 실시하였다.Samples were prepared by fixing the reaction temperature at 95°C, LB4-1 solution (Chelex-100S added), and tapping 4 times, changing the reaction time to 5 to 15 minutes each, and proceeding with bacterial lysis. qPCR was performed using F-primer for Gram-positive bacteria and 16s primer for Gram-negative bacteria.

① 그람양성균 S. sobrinus , S. mutans와 그람음성균 E. corrodens (1×107 CFU/mL)에 10% Chelex-100S가 첨가된 L4 세균 용해액 1 mL을 처리하여 95℃에서 각각 5, 10, 15분씩 반응시키면서 4회의 tapping을 실시하여 세균을 용해 시켰다.① Gram-positive bacteria S. sobrinus , S. mutans and Gram-negative bacteria E. corrodens (1×10 7 CFU/mL) was treated with 1 mL of L4 bacterial lysate containing 10% Chelex-100S and incubated at 95°C for 5, 10, and 15 minutes, respectively, while tapping four times to dissolve the bacteria.

② 원심분리 (12000 rpm, 10분)를 실시하여 상층액 1 μL를 qPCR의 template로 사용하고 F-primer & 16s primer를 이용하여 qPCR을 실시하였다. 양성대조군은 각 세균의 DNA, 음성 대조군은 DW를 사용하였다.② Centrifugation (12000 rpm, 10 minutes) was performed, 1 μL of the supernatant was used as a template for qPCR, and qPCR was performed using F-primer & 16s primer. DNA of each bacterium was used as a positive control, and DW was used as a negative control.

③ 그 결과, 1×107 CFU/mL의 세균에 대해, 95℃에서 10분과 15분은 유사한 Ct값을 나타내었으므로 반응시간은 10분으로 선정하였다. 단, 95℃에서 열처리되는 경우 반응에 사용되는 tube 가 뜨거운 상태이므로 사용에 주의가 필요하고 바로 샘플을 회수하기 어렵다. ③ As a result, for 1×10 7 CFU/mL bacteria, 10 and 15 minutes at 95°C showed similar Ct values, so the reaction time was selected as 10 minutes. However, when heat treatment is performed at 95℃, the tube used in the reaction is hot, so caution is required when using it, and it is difficult to immediately recover the sample.

반응시간 변경에 따른 qPCR 결과(3종 세균, 95℃)는 표 5에 나타냈다.The qPCR results (3 types of bacteria, 95°C) according to change in reaction time are shown in Table 5.

BacteriaBacteria Ct valueCT value Positive controlPositive control 반응 온도 95℃Reaction temperature 95℃ 5분5 minutes 10분10 minutes 15분15 minutes F-primerF-primer S. S. sobrinussobrinus 18.1318.13 25.9825.98 24.3624.36 24.1424.14 S. S. mutansmutans 18.118.1 26.6026.60 25.8425.84 25.8225.82 16s primer16s primer E. E. corrodenscorrodens 18.9218.92 23.8023.80 22.9822.98 22.1522.15

다음으로는, 반응온도 70℃, LB4-1 용액 (Chelex-100S 추가), vortexing 4회를 고정하고, 반응시간을 각각 10 ~ 30분으로 변경하며 세균 용해를 진행하여 샘플을 준비하였다. S. mutans은 S.m PP를 이용하여 qPCR을 실시하였다.Next, samples were prepared by fixing the reaction temperature at 70°C, LB4-1 solution (Chelex-100S added), and vortexing 4 times, changing the reaction time to 10 to 30 minutes each, and proceeding with bacterial lysis. For S. mutans, qPCR was performed using Sm PP.

① 그람양성균 S. mutans (1×107 CFU/mL)에 10% Chelex-100S가 첨가된 LB4-1 용액 1 mL을 처리하여, 70℃에서 각각 10, 20, 30분씩 반응시키면서 4회의 vortexing을 실시하여 세균을 용해 시켰다.① Gram-positive bacteria S. mutans (1×10 7 CFU/mL) was treated with 1 mL of LB4-1 solution containing 10% Chelex-100S, and the bacteria were dissolved by vortexing four times at 70°C for 10, 20, and 30 minutes, respectively. .

② 원심분리 (12000 rpm, 10분)를 실시하여 상층액 5 μL를 qPCR의 template로 사용하고 S. mutans primer-probe (S.m PP)를 이용하여 qPCR을 실시하였다. 10 μL 2X master mix, 2 μL 세균 PP (S.m PP), 3 μL DW로 최종 20 μL를 맞추어 qPCR 장비에서 초기 변성(95℃; 10분-1 cycle)을 시킨 후 2-step PCR 조건, 변성 95℃; 15초, 결합 & 신장 60℃; 1분-45 cycles로 실시하였다. ② Centrifugation (12000 rpm, 10 minutes) was performed, 5 μL of the supernatant was used as a template for qPCR, and qPCR was performed using S. mutans primer-probe ( Sm PP). Mix the final 20 μL with 10 μL 2X master mix, 2 μL bacterial PP ( Sm PP), and 3 μL DW, and perform initial denaturation (95°C; 10 minutes - 1 cycle) in a qPCR equipment. 2-step PCR conditions, denaturation 95 ℃; 15 seconds, binding & elongation 60°C; It was carried out for 1 minute - 45 cycles.

③ 그 결과, 1×107 CFU/mL의 S. mutans에 대해 70℃ 반응시 시간이 길어질수록 Ct값이 감소하였으며, 95℃ 10분 반응과 비교하였을 때 20분이 유사한 결과를 나타내었다. 따라서, 70℃에서 반응시 20분 이상의 반응시간이 필요할 것으로 판단하였다. 70℃ 반응은 tube가 뜨겁지 않아 바로 샘플 회수가 가능하다. ③ As a result , for 1 Therefore, it was determined that a reaction time of more than 20 minutes would be necessary for reaction at 70°C. In the 70℃ reaction, the tube is not hot, so sample recovery is possible right away.

반응시간 변경에 따른 qPCR 결과(S. mutans, 70℃)는 표 6 및 도 3에 나타냈다.The qPCR results (S. mutans, 70°C) according to change in reaction time are shown in Table 6 and Figure 3.

BacteriaBacteria Ct value CT value Positive controlPositive control 반응 온도 70℃Reaction temperature 70℃ 95℃95℃ 10분10 minutes 20분20 minutes 30분30 minutes 10분10 minutes S.m-primer Sm -primer S. S. mutansmutans 18.9418.94 26.5226.52 25.4825.48 22.6422.64 25.6425.64

(3) Chelex-100 종류 및 농도(3) Chelex-100 type and concentration

Chelex-100 종류별: dry mesh size에 따라 small, medium, large 형태의 제품으로 분자생물학적 등급의 양이온 교환 수지의 Chelex-100 small (S, 75-150 ㎛)과, 일반적인 분석적 등급의 양이온 교환 수지 Chelex-100 medium (M, 150-300 ㎛), Chelex-100 large (L, 300-1180 ㎛) 중 wet bead size가 가장 큰 Chelex-100L을 사용하여 샘플을 준비하였다. Chelex-100 by type: Small, medium, and large products depending on dry mesh size. Chelex-100 small (S, 75-150 ㎛), a molecular biology grade cation exchange resin, and Chelex-100, a general analytical grade cation exchange resin. Samples were prepared using Chelex-100L, which has the largest wet bead size among 100 medium (M, 150-300 ㎛) and Chelex-100 large (L, 300-1180 ㎛).

① 그람양성균 S. sobrinus , S. mutans (1×107 CFU/mL)에 반응온도 95℃, 반응시간 10분을 고정하고 10% Chelex-100S와 10% Chelex-100L에 LB4-1 세균 용해액 1 mL을 처리 후 물리적 자극 (Vortex & Tapping)에 따른 샘플을 준비하였다.① Gram-positive bacteria S. sobrinus , S. mutans (1×10 7 CFU/mL), reaction temperature was fixed at 95°C, reaction time was 10 minutes, and 10% Chelex-100S and 10% Chelex-100L were treated with 1 mL of LB4-1 bacterial lysate, followed by physical stimulation (Vortex & Samples were prepared according to Tapping.

S. sobrinus , S. mutans 세균 lysate를 template로 사용하고, F-primer를 이용하여 qPCR을 실시하고 Ct값이 낮은 조건으로 선정하였다. S. sobrinus , S. mutans Bacterial lysate was used as a template, qPCR was performed using F-primer, and conditions with a low Ct value were selected.

③ 그 결과, Chelex-100S가 선정되었다.③ As a result, Chelex-100S was selected.

Chelex-100 종류에 따른 qPCR 분석 결과는 표 7에 나타냈다. The qPCR analysis results according to Chelex-100 type are shown in Table 7.

BacteriaBacteria Ct valueCT value ChelexChelex -100S-100S ChelexChelex -100L-100L 양성positivity 95℃95℃ 양성positivity 95℃95℃ VorVor TapTap VorVor TapTap F-primerF-primer S. S. sobrinussobrinus 13.913.9 19.819.8 20.120.1 13.913.9 21.421.4 21.621.6 S. S. mutansmutans 2121 26.826.8 26.626.6 2121 28.228.2 28.428.4

Chelex-100S 농도별: Chelex-100 종류 중 선정된 Chelex-100S에 대해 농도 (5% ~ 20%)를 변경하여 준비한 샘플로 qPCR을 실시하였다.By concentration of Chelex-100S: qPCR was performed on samples prepared by changing the concentration (5% to 20%) of Chelex-100S, which was selected among Chelex-100 types.

① 그람양성균 S. sobrinus , S. mutans (1×107 CFU/mL)에 반응온도 95℃, 반응시간 10분, 물리적 자극 tapping을 고정하고, 2.5%, 5%, 10%, 15%, 20% Chelex-100S가 첨가된 LB4-1 세균 용해액 1 mL을 처리하여 세균을 용해 시켰다.① Gram-positive bacteria S. sobrinus , S. mutans (1×10 7 CFU/mL) with fixed reaction temperature of 95°C, reaction time of 10 minutes, and physical stimulation by tapping, and 2.5%, 5%, 10%, 15%, and 20% Chelex-100S added to LB4-1. Bacteria were lysed by treating with 1 mL of bacterial lysate.

S. sobrinus , S. mutans , E. corrodens 세균 lysate를 template로 사용하고, F-primer & 16s primer를 이용하여 qPCR을 실시하여 Chelex-100S의 농도를 선정하였다. S. sobrinus , S. mutans , and E. corrodens bacterial lysates were used as templates, and qPCR was performed using F-primer & 16s primers to select the concentration of Chelex-100S.

③ 그 결과, 10% Chelex-100S가 선정되었다.③ As a result, 10% Chelex-100S was selected.

Chelex-100S 농도에 따른 qPCR 분석 결과는 표 8에 나타냈다. The qPCR analysis results according to Chelex-100S concentration are shown in Table 8.

BacteriaBacteria Cycle threshold value (Cycle threshold value ( Ct값Ct value )) 양성positivity ChelexChelex -100S-100S 2.5% 2.5% 5% 5% 10%10% 15%15% 20%20% F-primerF-primer S. S. sobrinussobrinus 19.8619.86 27.3227.32 27.9527.95 26.7626.76 26.9726.97 26.5626.56 S. S. mutansmutans 18.4718.47 27.0627.06 26.6326.63 26.0226.02 25.9325.93 26.9226.92 16s primer16s primer E. E. corrodenscorrodens 18.4518.45 24.7124.71 23.8223.82 22.4822.48 22.3022.30 22.1422.14

(4) 물리적 자극 최적화 (4) Optimization of physical stimulation

반응온도 95℃, 10분과 LB4-1 용액 (Chelex-100S 추가)을 고정하고, 물리적 자극 여부를 각각 그대로 두기, vortexing, tapping 으로 변화시키면서 세균 용해를 진행하여 샘플을 준비하였다. 그람 양성균은 F-primer로, 그람 음성균은 16s primer를 이용하여 qPCR을 실시하였다.Samples were prepared by fixing the LB4-1 solution (Chelex-100S added) at a reaction temperature of 95°C for 10 minutes and proceeding with bacterial lysis while changing the physical stimulation between leaving as is, vortexing, and tapping. qPCR was performed using F-primer for Gram-positive bacteria and 16s primer for Gram-negative bacteria.

① 그람양성균 S. sobrinus , S. mutans와 그람음성균 E. corrodens (1×107 CFU/mL)에 10% Chelex-100S가 첨가된 L4 세균 용해액 1 mL을 처리하여 95℃에서 10분 반응시키면서 각각 그대로 두기, 4회의 tapping과 4회의 vortexing을 실시하여 세균을 용해 시켰다.① Gram-positive bacteria S. sobrinus , S. mutans and Gram-negative bacteria E. corrodens (1×10 7 CFU/mL) was treated with 1 mL of L4 bacterial lysate with 10% Chelex-100S added, reacted at 95°C for 10 minutes, left as is, then 4 times tapping and 4 times vortexing to remove bacteria. dissolved.

② 원심분리 (12000 rpm, 10분)를 실시하여 상층액 1 μL를 qPCR의 template로 사용하고 F-primer & 16s primer를 이용하여 qPCR을 실시하였다. 양성대조군은 각 세균의 DNA, 음성 대조군은 DW를 사용하였다. ② Centrifugation (12000 rpm, 10 minutes) was performed, 1 μL of the supernatant was used as a template for qPCR, and qPCR was performed using F-primer & 16s primer. DNA of each bacterium was used as a positive control, and DW was used as a negative control.

③ 그 결과, 1×107 CFU/mL의 세균에 대해, 물리적 자극이 없는 것에 비해 vortexing이나 tapping을 시행하는 것이 좋으나, 세균 용해에 있어서 vortexing과 tapping은 큰 차이 없이 유사함을 확인하였다.③ As a result, it was confirmed that vortexing or tapping is better for 1

물리적 자극 여부에 의한 qPCR 분석 결과 (3종 세균)는 표 9 및 도 4에 나타냈다. The qPCR analysis results (3 types of bacteria) with and without physical stimulation are shown in Table 9 and Figure 4.

BacteriaBacteria Ct value CT value Positive controlPositive control StaticStatic VortexingVortexing TappingTapping F-primerF-primer S. S. sobrinussobrinus 19.4719.47 27.4127.41 26.0126.01 26.4926.49 S. S. mutansmutans 18.1918.19 26.7826.78 25.7725.77 25.5925.59 16s primer16s primer E. E. corrodenscorrodens 18.618.6 24.7224.72 23.0723.07 22.3822.38

3. 세균 용해액 최종 선정3. Final selection of bacterial lysate

최적화된 세균 용해 조건을 이용하여 그람양성균 3종 (S. sobrinus , S. mutans, L. casei)에 대해 각각의 specific probe-primer - S. sobrinus probe-primer (S.s PP), S.m PP, L. casei probe-primer (L.c PP) - 를 제작하여 낮은 세균수에서 1차 선정 3종 세균 용해액을 적용하여 최종 세균 용해액을 선정하였다.Using optimized bacterial lysis conditions, specific probe-primer for each of the three Gram-positive bacteria ( S. sobrinus , S. mutans, L. casei ) - S. sobrinus probe-primer ( Ss PP) , Sm PP, and L. casei probe-primer ( Lc PP) - were produced and the final bacterial lysate was selected by applying the first three bacterial lysates at low bacterial counts.

이때, 양성대조군은 상용화된 2종 시약- PCRopsisTM Reagent SRVD (Entopsis), One-Step DNA/RNA extraction buffer (CHAIBio)를 추가하여 최종 세균 용해액 선정 기준으로 하였다. At this time, two commercially available reagents - PCRopsis TM Reagent SRVD (Entopsis) and One-Step DNA/RNA extraction buffer (CHAIBio) were added to the positive control group, which was used as the standard for selecting the final bacterial lysate.

① 세균 S. sobrinus , S. mutans , L. casei (2×103 & 4×103 CFU/mL)에 1차로 선정된 3종의 세균 용해액 1 mL (lysis buffer 990 μL + 세균 10 μL)을 첨가하여 반응온도 95℃, 반응시간 10분, 물리적 자극 tapping, 10% Chelex-100S 처리하여 세균 lysate를 준비하였다. 세균 용해액의 양성대조군은 상용화된 시약 고마 SRVD와 린인 One-step을 처리하여 세균 lysate를 준비하였다.① Bacteria S. sobrinus , S. mutans , L. casei (2×10 3 & 4×10 3 CFU/mL), 1 mL of 3 types of bacterial lysate (lysis buffer 990 μL + bacteria 10 μL) was added, reaction temperature 95°C, reaction time 10 minutes, physical stimulation tapping, 10% Bacterial lysate was prepared by treatment with Chelex-100S. As a positive control group of bacterial lysate, bacterial lysate was prepared by treating with commercially available reagents Goma SRVD and Linin One-step.

② 세균 용해액의 용해력을 확인하기 위해, 원심분리 (12000 rpm, 10분)를 실시하여 상층액 5 μL를 qPCR의 template로 사용하고 각각의 세균 PP를 이용하여 qPCR을 실시하였다. 10 μL 2X master mix, 2 μL 세균 PP (S.s PP, S.m PP, L.c PP), 3 μL DW로 최종 20 μL를 맞추어 qPCR 장비에서 초기 변성(95℃; 10분-1 cycle)을 시킨 후 2-step PCR 조건, 변성 95℃; 15초, 결합 & 신장 60℃; 1분-45 cycles로 실시하였다.② To check the lytic power of the bacterial lysate, centrifugation (12000 rpm, 10 minutes) was performed, 5 μL of the supernatant was used as a template for qPCR, and qPCR was performed using each bacterial PP. Mix the final 20 μL with 10 μL 2X master mix, 2 μL bacterial PP (S.s PP, S.m PP, L.c PP), and 3 μL DW, and perform initial denaturation (95°C; 10 minutes - 1 cycle) in a qPCR device. 2- step PCR conditions, denaturation 95°C; 15 seconds, binding & elongation 60°C; It was carried out for 1 minute - 45 cycles.

③ qPCR의 양성대조군은 각 세균의 DNA, 음성 대조군은 DW를 사용하였다. ③ The positive control group of qPCR used DNA of each bacteria, and the negative control group used DW.

④ 그 결과, 수행한 세균 모두에서 L4의 세균 용해액에서 PCR 증폭이 확인되어 (Ct값 33 ~ 40, 세균 10개 기준) 1-step 전처리용 세균 용해액으로 최종 선정하였다. 상용화된 2종의 양성대조군도 PCR 증폭이 이루어지나, 적은 세균 수에 대해서는 증폭되지 않은 세균 종도 있었으며 선정된 L4의 세균 lysate의 PCR 보다 높은 Ct값 (38 ~ 40, 세균 10개 기준)을 나타냈다.④ As a result, PCR amplification was confirmed in the bacterial lysate of L4 for all bacteria performed (Ct value 33 ~ 40, based on 10 bacteria), and it was finally selected as the bacterial lysate for 1-step pretreatment. Two commercially available positive controls also achieved PCR amplification, but for small numbers of bacteria, there were bacterial species that were not amplified, and they showed higher Ct values (38 to 40, based on 10 bacteria) than the PCR of the selected L4 bacterial lysate.

1-step 전처리용 세균 용해액 최적화를 위한 qPCR 결과는 표 10 및 도 5에 나타냈다.The qPCR results for optimizing the bacterial lysate for 1-step pretreatment are shown in Table 10 and Figure 5.

BacteriaBacteria Number of bacteria
(CFU/mL)
Number of bacteria
(CFU/mL)
Ct valueCT value
Positive controlPositive control LB1-1LB1-1 LB4-1LB4-1 LB4-2LB4-2 SRVDS.R.V.D. One stepOne step S.S. sobrinussobrinus 4 x 103 4 x 10 3 15.3715.37 37.3037.30 36.3136.31 38.0338.03 36.9836.98 37.4637.46 2 x 103 2 x 10 3 15.3715.37 36.3736.37 36.4336.43 -- 38.9838.98 37.9537.95 S.S. mutansmutans 4 x 103 4 x 10 3 17.7017.70 33.5933.59 33.1433.14 34.2034.20 36.6736.67 38.1838.18 2 x 103 2 x 10 3 17.7017.70 34.8334.83 34.8434.84 35.8235.82 36.8836.88 36.8136.81 L. L. caseicasei 4 x 103 4 x 10 3 19.3219.32 -- 38.5638.56 38.2638.26 39.3239.32 38.8338.83 2 x 103 2 x 10 3 19.3219.32 -- 39.6739.67 -- -- --

결론적으로, 다음과 같은 최적화된 1-step 전처리 프로토콜을 확립하였다(Lab. scale 기준).In conclusion, the following optimized 1-step pretreatment protocol was established (based on Lab. scale).

- 세균 용해액: LB4-1 (SDS/nonidetP-40 기반) + Chelex-100S (10% w/v)- Bacterial lysate: LB4-1 (based on SDS/nonidetP-40) + Chelex-100S (10% w/v)

- 열처리: 온도 95℃, 10분 (또는 70℃, 20분 이상)- Heat treatment: temperature 95℃, 10 minutes (or 70℃, more than 20 minutes)

- 물리적 자극: Vortexing 4회 이상 (10분 기준, 2분 30초 간격으로 시행)- Physical stimulation: Vortexing 4 times or more (performed at 2 minutes and 30 second intervals for 10 minutes)

이상으로 본 발명의 특정한 부분을 상세히 기술하였는 바, 당업계의 통상의 지식을 가진 자에게 있어서, 이러한 구체적 기술은 단지 바람직한 실시예일 뿐이며, 이에 의해 본 발명의 범위가 제한되는 것이 아닌 점은 명백할 것이다. 따라서, 본 발명의 실질적인 범위는 첨부된 청구항들과 그것들의 등가물에 의하여 정의된다고 할 것이다. As the specific parts of the present invention have been described in detail above, it is clear to those skilled in the art that these specific techniques are merely preferred embodiments and do not limit the scope of the present invention. will be. Accordingly, the substantial scope of the present invention will be defined by the appended claims and their equivalents.

Claims (7)

Tris-HCl, NaCl, SDS, Nonidet P-40 및 Chelex-100S를 포함하는 세균 용해액(lysis buffer)에 시료를 첨가하는 단계; 및
상기 시료가 첨가된 세균 용해액을 70 내지 95℃에서, 10 내지 30분 동안 반응시키면서, 볼텍싱(vortexing) 또는 탭핑(tapping)하는 단계를 포함하는 시료 전처리 방법.
Adding the sample to a bacterial lysis buffer containing Tris-HCl, NaCl, SDS, Nonidet P-40, and Chelex-100S; and
A sample pretreatment method comprising reacting the bacterial lysate to which the sample was added at 70 to 95°C for 10 to 30 minutes while vortexing or tapping.
제1항에 있어서, 상기 세균 용해액(lysis buffer)은 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.1 내지 0.2 % SDS, 1 % Nonidet P-40 및 2.5 내지 20 % Chelex-100S를 최종 농도로 포함하는 것을 특징으로 하는 시료 전처리 방법.The method of claim 1, wherein the bacterial lysis buffer (lysis buffer) contains 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.1 to 0.2 % SDS, 1 % Nonidet P-40, and 2.5 to 20 % Chelex-100S. A sample pretreatment method characterized by including the final concentration. 제1항에 있어서, 상기 시료는 타액인 것을 특징으로 하는 시료 전처리 방법. The sample preparation method according to claim 1, wherein the sample is saliva. 제3항에 있어서, 상기 시료는 스트렙토코커스 소브리누스(Streptococcus sobrinus), 스트렙토코커스 뮤탄스(Streptococcus mutans) 또는 아이케넬라 코로덴스(Eikenella corrodens)가 포함된 시료인 것을 특징으로 하는 시료 전처리 방법.The sample pretreatment method of claim 3, wherein the sample is a sample containing Streptococcus sobrinus, Streptococcus mutans , or Eikenella corrodens . 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.1 내지 0.2 % SDS, 1 % Nonidet P-40 및 2.5 내지 20 % Chelex-100S가 최종농도로 함유된 세균 용해액(lysis buffer)을 유효성분으로 포함하는 시료 전처리용 조성물.A bacterial lysis buffer containing a final concentration of 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.1 to 0.2 % SDS, 1 % Nonidet P-40, and 2.5 to 20 % Chelex-100S was used as the active ingredient. A composition for sample pretreatment comprising: 제5항에 있어서, 상기 시료는 타액인 것을 특징으로 하는 시료 전처리용 조성물.The composition for sample pretreatment according to claim 5, wherein the sample is saliva. 제6항에 있어서, 상기 시료는 스트렙토코커스 소브리누스(Streptococcus sobrinus), 스트렙토코커스 뮤탄스(Streptococcus mutans) 또는 아이케넬라 코로덴스(Eikenella corrodens)가 포함된 시료인 것을 특징으로 하는 시료 전처리용 조성물.The composition for sample pretreatment of claim 6, wherein the sample is a sample containing Streptococcus sobrinus, Streptococcus mutans , or Eikenella corrodens . .
KR1020220096546A 2022-08-03 2022-08-03 One step sample pretreatment method for rapid quantitative test of oral bacteria KR20240018800A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020220096546A KR20240018800A (en) 2022-08-03 2022-08-03 One step sample pretreatment method for rapid quantitative test of oral bacteria
PCT/KR2023/011397 WO2024029950A1 (en) 2022-08-03 2023-08-03 One-step sample pretreatment method for rapid quantitative testing of oral bacteria

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020220096546A KR20240018800A (en) 2022-08-03 2022-08-03 One step sample pretreatment method for rapid quantitative test of oral bacteria

Publications (1)

Publication Number Publication Date
KR20240018800A true KR20240018800A (en) 2024-02-14

Family

ID=89849617

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020220096546A KR20240018800A (en) 2022-08-03 2022-08-03 One step sample pretreatment method for rapid quantitative test of oral bacteria

Country Status (2)

Country Link
KR (1) KR20240018800A (en)
WO (1) WO2024029950A1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101467371B1 (en) 2010-12-14 2014-12-02 주식회사 피코팜 A Method of Purifying a Saliva

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060035684A (en) * 2006-04-04 2006-04-26 김연수 Method for extracting nucleic acids from human body fluids and compositions there for
KR101414828B1 (en) * 2010-11-30 2014-07-09 (주)휴먼패스 Method for pcr
KR101497525B1 (en) * 2013-05-29 2015-03-02 부경대학교 산학협력단 Method of extracting dna from marine organism

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101467371B1 (en) 2010-12-14 2014-12-02 주식회사 피코팜 A Method of Purifying a Saliva

Also Published As

Publication number Publication date
WO2024029950A1 (en) 2024-02-08

Similar Documents

Publication Publication Date Title
Domann et al. Culture-independent identification of pathogenic bacteria and polymicrobial infections in the genitourinary tract of renal transplant recipients
JP7055020B2 (en) Microfluidic measurement of biological response to drugs
Lu et al. Isolation and genotyping of Helicobacter pylori from untreated municipal wastewater
Gravekamp et al. Detection of seven species of pathogenic leptospires by PCR using two sets of primers
Holmes et al. Neer Award 2017: A rapid method for detecting Propionibacterium acnes in surgical biopsy specimens from the shoulder
Amita et al. Qualitative evaluation of mycobacterial DNA extraction protocols for polymerase chain reaction
CN108368539A (en) Nucleic acid purification in environment or biological sample
EP0626456A1 (en) Sample processing method for mycobacteria
Taylor-Brown et al. Culture-independent approaches to chlamydial genomics
Derzelle et al. Use of high-resolution melting and melting temperature-shift assays for specific detection and identification of Bacillus anthracis based on single nucleotide discrimination
CN110904250A (en) Multiple fluorescent quantitative PCR primer, kit and detection method for detecting multiple bacteria
Molander et al. A protocol for polymerase chain reaction detection of Enterococcus faecalis and Enterococcus faecium from the root canal
CN110343754A (en) A method of it is quickly detected for hematopoietic stem cell transplantation donor pathogenic microorganism
JP5745403B2 (en) Methods and kits for repairing nucleic acid sequences
Wu et al. Comparison of DNA extraction methods for human oral microbiome research.
Traverso et al. Morphologic, genetic, and biochemical characterization of Helicobacter magdeburgensis, a novel species isolated from the intestine of laboratory mice
EP3277809B1 (en) Isolation of nucleic acids
Yan et al. Cultivation and genomic characterization of the bile bacterial species from cholecystitis patients
KR20240018800A (en) One step sample pretreatment method for rapid quantitative test of oral bacteria
CN108866220B (en) Method and detection kit for detecting nasal flora
CN109266728B (en) A kind of method of damage and decorating site on gene location group DNA
US6391631B1 (en) Bacterial plasmids
Agbonlahor et al. A primal incrimination of Cedecea davisae with post-prostatectomy urinary tract infection in Nigeria
CN113151599A (en) Primer group, reagent, kit and detection method for detecting novel coronavirus
KR20140064918A (en) Molecular detection assay